HC Wainwright & Co. Maintains Buy on Gossamer Bio, Raises Price Target to $10
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Patrick Trucchio has maintained a Buy rating on Gossamer Bio (NASDAQ:GOSS) and increased the price target from $5 to $10.
January 08, 2024 | 11:27 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst reaffirms Buy rating on Gossamer Bio and raises price target from $5 to $10, potentially doubling investor optimism.
The increase in price target by a reputable analyst firm like HC Wainwright & Co. is a strong positive signal for investors, suggesting a bullish outlook on Gossamer Bio's stock. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100